Sandy Spring Bank’s Axsome Therapeutics AXSM Stock Holding History

Sandy Spring Bank’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-4,375	Closed	-$349K	–	1279
2024 Q1	$349K	Hold	4,375	–	–	0.02%	315
2023 Q4	$348K	Hold	4,375	–	–	0.02%	303
2023 Q3	$306K	Hold	4,375	–	–	0.02%	298
2023 Q2	$314K	Hold	4,375	–	–	0.02%	300
2023 Q1	$270K	Sell	4,375 -1,075	-20%	-$70.6K	0.02%	316
2022 Q4	$420K	Hold	5,450	–	–	0.03%	266
2022 Q3	$243K	Hold	5,450	–	–	0.02%	306
2022 Q2	$209K	Hold	5,450	–	–	0.01%	321
2022 Q1	$226K	Hold	5,450	–	–	0.01%	322
2021 Q4	$206K	Hold	5,450	–	–	0.01%	331
2021 Q3	$180K	Sell	5,450 -3,305	-38%	-$129K	0.01%	341
2021 Q2	$591K	Hold	8,755	–	–	0.03%	242
2021 Q1	$496K	Hold	8,755	–	–	0.03%	253
2020 Q4	$713K	Hold	8,755	–	–	0.04%	217
2020 Q3	$624K	Hold	8,755	–	–	0.04%	212
2020 Q2	$720K	Hold	8,755	–	–	0.05%	201
2020 Q1	$515K	Hold	8,755	–	–	0.05%	210
2019 Q4	$905K	Hold	8,755	–	–	0.07%	196
2019 Q3	$177K	Hold	8,755	–	–	0.01%	308
2019 Q2	$225K	Hold	8,755	–	–	0.02%	286
2019 Q1	$125K	Hold	8,755	–	–	0.01%	334
2018 Q4	$25K	Hold	8,755	–	–	﹤0.01%	534
2018 Q3	$30K	Hold	8,755	–	–	﹤0.01%	528
2018 Q2	$28K	Hold	8,755	–	–	﹤0.01%	536
2018 Q1	$21K	Hold	8,755	–	–	﹤0.01%	593
2017 Q4	$49K	Hold	8,755	–	–	﹤0.01%	451
2017 Q3	$49K	Hold	8,755	–	–	﹤0.01%	443
2017 Q2	$48K	Hold	8,755	–	–	﹤0.01%	461
2017 Q1	$34K	Hold	8,755	–	–	﹤0.01%	511
2016 Q4	$59K	Buy	+8,755	New	+$61.5K	0.01%	417

Other funds holding AXSM

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sandy Spring Bank's AXSM Position: Q2 2024 in Review

Sandy Spring Bank sold out of Axsome Therapeutics (AXSM) in Q2 2024, closing a stake of 4,375 shares — an estimated $349K sold.

Sandy Spring Bank first reported a position in AXSM in Q4 2016 and held it in 30 quarters. The position peaked at $905K in Q4 2019. 256 funds tracked by Wall St. Rank hold AXSM as of Q2 2024.

Sandy Spring Bank reported no remaining Axsome Therapeutics position as of Q2 2024 after selling out during the quarter.
Sandy Spring Bank sold 4,375 Axsome Therapeutics shares in Q2 2024, an estimated $349K.
Sandy Spring Bank first reported a position in Axsome Therapeutics in Q4 2016 and held it in 30 quarters.
Sandy Spring Bank's Axsome Therapeutics position peaked at $905K in Q4 2019.
256 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2024.

Based on Sandy Spring Bank's 13F filing for Q2 2024, filed 6 Aug 2024.